Filgrastim is used for treatment of neutropenia and infection in people who are receiving bone marrow suppressing drugs for cancer treatment. Neutropenia is a condition referring to a low number of neutrophils in the blood.
Neutrophils are a white blood cell important in defending the body against infections.
Neutropenia can be a side effect of drugs such as AZT and cancer treatments. Side effects Bone pain is a common side effect. Use of filgrastim should be avoided for 24 hours before and after chemotherapy. Dosage Filgrastim is given intravenously or subcutaneously. Safety is not established in pregnant or breast feeding women.